Highlights
NASDAQ: ALNA       Allena Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
1.18   -0.151 (11.34%)  1.16 - 1.21  1,603,983

Overview

 
Avg Volume (4 weeks):627,363
4 Weeks Range:1.16 - 1.63
4 Weeks Price Volatility (%):
4.26%
52 Weeks Range:0.525 - 3.39
52 Weeks Price Volatility (%):
22.86%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Allena Pharmaceuticals Inc is a US-based late-stage clinical biopharmaceutical company. It is developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. The company focuses on metabolic disorders which result in excess accumulation of certain metabolites, such as oxalate and urate, that can cause kidney stones, damage the kidney, and lead to chronic kidney disease (CKD), and end-stage renal disease. Its key product candidates are ALLN-177 which is an oral enzyme therapeutic developing for the treatment of hyperoxaluria, and ALLN-346 is being developed for patients with hyperuricemia and moderate to severe CKD.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2868  2919  604  3175 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 0.728+0.076 
 LK 1.38+1.38 
 NIO 43.30-2.06 
 NAOV 2.00+1.291 
 NXTD 0.557+0.147 
 HTZ 0.00-1.75 
 PLTR 22.87-2.80 
 GPOR 0.1380.00 
 WORK 42.61-1.23 
 FCEL 6.861-2.189